Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Vesicare available in U.S.

Jan. 21, 2005

BMP-7 effective in preclinical models of Parkinson's disease and kidney injury

Jan. 21, 2005

TRPV1 agonist effective against urinary incontinence in preclinical model

Jan. 19, 2005

Clinical trial confirms the benefits of conivaptan in the management of hyponatremia

Jan. 18, 2005

KRX-101 phase II/III program recommended to continue to phase III

Jan. 14, 2005

Novel, selective estrogen receptor beta agonists in early development at Lilly

Jan. 5, 2005

Synthesis and biological activity of YM-92088, a novel nonsteroidal androgen receptor antagonist

Jan. 4, 2005

NDA submission for premature ejaculation treatment dapoxetine hydrochloride

Dec. 30, 2004

FDA approves Enablex for overactive bladder

Dec. 27, 2004

Improved PDE5 inhibitors selected for clinical studies on erectile dysfunction

Dec. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...